Post-partum depression (PPD) develops after childbirth and affects both the mother’s and the infant’s health by preventing healthy bonding.
Brexanolone inhibits key systemic inflammatory pathways associated with post-partum depression
Post-partum depression (PPD) develops after childbirth and affects both the mother's and the infant's health by preventing healthy bonding.